Gene Symbol | Gene ID | Gene Info |
---|---|---|
Glis2
|
ENSMUSG00000014303.7 | GLIS family zinc finger 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_4597211_4598575 | Glis2 | 3180 | 0.160919 | 0.48 | 1.0e-04 | Click! |
chr16_4596912_4597063 | Glis2 | 2274 | 0.199304 | 0.45 | 3.3e-04 | Click! |
chr16_4598581_4599476 | Glis2 | 2135 | 0.207872 | 0.42 | 8.3e-04 | Click! |
chr16_4586076_4586257 | Glis2 | 8547 | 0.124572 | -0.40 | 1.5e-03 | Click! |
chr16_4604969_4605233 | Glis2 | 3526 | 0.149282 | 0.38 | 3.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_70119024_70120981 | 12.99 |
Ncan |
neurocan |
871 |
0.35 |
chr7_79505833_79506958 | 10.59 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr5_116589538_116590511 | 8.92 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr7_79500711_79501247 | 8.80 |
Mir9-3hg |
Mir9-3 host gene |
858 |
0.39 |
chr9_21196536_21198489 | 8.79 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr2_158610228_158611991 | 8.00 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr14_66344363_66345813 | 7.93 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr7_140080531_140082545 | 7.88 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr7_24485614_24487418 | 7.83 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr5_131534533_131535200 | 7.75 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr10_80300884_80302968 | 7.08 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr3_94478073_94479450 | 6.79 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr11_98329171_98329487 | 6.75 |
Neurod2 |
neurogenic differentiation 2 |
319 |
0.79 |
chr3_88206822_88208169 | 6.64 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr7_79507974_79509311 | 6.41 |
A330074H02Rik |
RIKEN cDNA A330074H02 gene |
1720 |
0.18 |
chr6_90781027_90782541 | 6.17 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr3_88214322_88216234 | 6.09 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr5_37248332_37249378 | 5.88 |
Crmp1 |
collapsin response mediator protein 1 |
1570 |
0.39 |
chr15_25415052_25415352 | 5.86 |
Gm48957 |
predicted gene, 48957 |
139 |
0.9 |
chr2_181313043_181314281 | 5.84 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr11_81968072_81969328 | 5.80 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
243 |
0.91 |
chr5_135077129_135077753 | 5.76 |
Vps37d |
vacuolar protein sorting 37D |
825 |
0.4 |
chr11_96306504_96308444 | 5.76 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
564 |
0.48 |
chr5_103210548_103211780 | 5.73 |
Mapk10 |
mitogen-activated protein kinase 10 |
109 |
0.98 |
chr11_87759834_87761999 | 5.64 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr1_84694736_84695168 | 5.61 |
Mir5126 |
microRNA 5126 |
887 |
0.41 |
chr14_122461803_122462503 | 5.60 |
Zic5 |
zinc finger protein of the cerebellum 5 |
2132 |
0.2 |
chr8_123413418_123414506 | 5.60 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr8_123891512_123893657 | 5.58 |
Acta1 |
actin, alpha 1, skeletal muscle |
2167 |
0.16 |
chr15_98989928_98991865 | 5.56 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr5_116590520_116593206 | 5.51 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr16_81201314_81201888 | 5.50 |
Ncam2 |
neural cell adhesion molecule 2 |
844 |
0.72 |
chr3_17795553_17795854 | 5.49 |
Mir124a-2 |
microRNA 124a-2 |
41 |
0.5 |
chr10_81481331_81481482 | 5.49 |
Celf5 |
CUGBP, Elav-like family member 5 |
1266 |
0.2 |
chr11_103775036_103776082 | 5.22 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
1409 |
0.37 |
chr14_122478089_122479067 | 5.21 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr7_25004827_25006284 | 5.19 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr5_120433178_120434996 | 5.16 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr2_178141581_178143125 | 5.16 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr3_88208231_88208654 | 5.06 |
Gm3764 |
predicted gene 3764 |
1030 |
0.28 |
chr6_88872932_88873571 | 4.99 |
Podxl2 |
podocalyxin-like 2 |
794 |
0.47 |
chr15_79161476_79163015 | 4.95 |
Sox10 |
SRY (sex determining region Y)-box 10 |
2229 |
0.15 |
chr19_6418703_6419936 | 4.92 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr6_83179353_83180686 | 4.89 |
Dctn1 |
dynactin 1 |
406 |
0.67 |
chr7_54835204_54836499 | 4.86 |
Luzp2 |
leucine zipper protein 2 |
236 |
0.94 |
chr11_32001099_32002296 | 4.85 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr2_105675959_105678109 | 4.82 |
Pax6 |
paired box 6 |
905 |
0.54 |
chr15_87626925_87627959 | 4.79 |
Tafa5 |
TAFA chemokine like family member 5 |
2212 |
0.46 |
chr9_41582824_41584205 | 4.77 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr11_41999400_42000640 | 4.73 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr19_4711641_4712943 | 4.73 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
92 |
0.94 |
chr9_58197310_58202560 | 4.72 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chrX_7638310_7639997 | 4.71 |
Syp |
synaptophysin |
152 |
0.88 |
chr7_25152042_25153378 | 4.61 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
253 |
0.87 |
chr13_42709652_42710400 | 4.57 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr13_99443316_99444666 | 4.51 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr6_13835523_13837039 | 4.50 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr13_83717521_83718816 | 4.50 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr19_5096057_5096487 | 4.47 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
2110 |
0.12 |
chr1_92849002_92850443 | 4.46 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr14_64588312_64589438 | 4.44 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr10_34299043_34301066 | 4.40 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr9_91369028_91370469 | 4.40 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr10_84756349_84757352 | 4.40 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
788 |
0.69 |
chr2_105678552_105679922 | 4.39 |
Pax6 |
paired box 6 |
630 |
0.68 |
chr2_105668422_105670370 | 4.34 |
Pax6 |
paired box 6 |
461 |
0.65 |
chr1_75277211_75278430 | 4.33 |
Resp18 |
regulated endocrine-specific protein 18 |
464 |
0.62 |
chr3_8509825_8511666 | 4.28 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr9_20745303_20746611 | 4.27 |
Olfm2 |
olfactomedin 2 |
392 |
0.82 |
chr9_110051810_110053856 | 4.25 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr15_82255980_82257145 | 4.21 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chr1_132541040_132543287 | 4.18 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr2_116068937_116070512 | 4.15 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
1756 |
0.28 |
chr9_110053895_110054422 | 4.03 |
Map4 |
microtubule-associated protein 4 |
2106 |
0.22 |
chr2_18042311_18043883 | 4.01 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr17_57086046_57086370 | 4.01 |
Tubb4a |
tubulin, beta 4A class IVA |
1574 |
0.18 |
chr7_19282758_19283683 | 4.01 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
585 |
0.49 |
chr7_28301100_28302593 | 3.98 |
Dll3 |
delta like canonical Notch ligand 3 |
74 |
0.93 |
chr5_128432188_128433399 | 3.97 |
Tmem132d |
transmembrane protein 132D |
284 |
0.89 |
chr6_112945034_112945954 | 3.96 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
1260 |
0.31 |
chr14_25610327_25611867 | 3.92 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chr12_117688775_117690161 | 3.91 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr13_58807413_58808951 | 3.90 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
99 |
0.95 |
chr3_80800286_80803016 | 3.89 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr7_126952524_126952951 | 3.88 |
Sez6l2 |
seizure related 6 homolog like 2 |
1130 |
0.2 |
chr10_127530701_127531818 | 3.87 |
Nxph4 |
neurexophilin 4 |
3300 |
0.13 |
chr14_4649261_4650460 | 3.87 |
Gm3239 |
predicted gene 3239 |
14332 |
0.11 |
chr18_35964551_35965976 | 3.85 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr13_83732205_83734272 | 3.84 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr10_127078876_127080327 | 3.83 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
694 |
0.42 |
chr9_91353601_91354899 | 3.78 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
3297 |
0.14 |
chr15_103026302_103028215 | 3.78 |
Hoxc4 |
homeobox C4 |
7137 |
0.09 |
chr19_44758783_44762005 | 3.76 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr9_124439879_124441093 | 3.73 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
382 |
0.83 |
chr5_30106879_30107999 | 3.71 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
1353 |
0.28 |
chr4_139829905_139830959 | 3.69 |
Pax7 |
paired box 7 |
2575 |
0.32 |
chr18_77560987_77561705 | 3.67 |
Rnf165 |
ring finger protein 165 |
3263 |
0.29 |
chrX_58033180_58034063 | 3.62 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr2_105680581_105683424 | 3.59 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr2_74722101_74723871 | 3.58 |
Hoxd4 |
homeobox D4 |
1008 |
0.22 |
chrX_58030987_58032527 | 3.55 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr1_99772154_99773556 | 3.53 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr11_61453075_61454398 | 3.52 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr2_113828248_113829427 | 3.50 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr4_36950134_36952137 | 3.50 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
88 |
0.97 |
chr5_30104769_30106082 | 3.46 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
66 |
0.75 |
chr2_70564530_70567543 | 3.46 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr13_34127276_34127957 | 3.45 |
Tubb2b |
tubulin, beta 2B class IIB |
2738 |
0.15 |
chr12_29527851_29528002 | 3.45 |
Myt1l |
myelin transcription factor 1-like |
458 |
0.84 |
chr9_91363965_91365514 | 3.43 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr7_62420525_62420893 | 3.41 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr8_94999966_95000377 | 3.41 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
710 |
0.55 |
chr3_89245218_89245909 | 3.38 |
Trim46 |
tripartite motif-containing 46 |
309 |
0.49 |
chr1_135579927_135581701 | 3.38 |
Gm4793 |
predicted gene 4793 |
3959 |
0.2 |
chr2_163438209_163439457 | 3.37 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr5_120426818_120428597 | 3.37 |
Lhx5 |
LIM homeobox protein 5 |
3992 |
0.15 |
chr10_81024569_81025640 | 3.36 |
Gm16099 |
predicted gene 16099 |
21 |
0.8 |
chr1_42696247_42696979 | 3.32 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
845 |
0.43 |
chr10_84757399_84758243 | 3.32 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1759 |
0.41 |
chr2_70561988_70564432 | 3.32 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr11_71753008_71753259 | 3.31 |
Wscd1 |
WSC domain containing 1 |
1757 |
0.33 |
chr5_111421306_111422790 | 3.30 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr7_34651302_34651863 | 3.28 |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
1255 |
0.32 |
chr6_8955848_8957226 | 3.27 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chr6_91409540_91411888 | 3.25 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
649 |
0.42 |
chr11_116919008_116919761 | 3.22 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
521 |
0.75 |
chr7_18926045_18927019 | 3.22 |
Nova2 |
NOVA alternative splicing regulator 2 |
644 |
0.54 |
chr8_117259792_117260803 | 3.22 |
Cmip |
c-Maf inducing protein |
3180 |
0.33 |
chr6_113193892_113195750 | 3.21 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
563 |
0.7 |
chr10_80298461_80300404 | 3.20 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr7_16946370_16947636 | 3.20 |
Pnmal2 |
PNMA-like 2 |
2321 |
0.14 |
chr7_126276115_126276973 | 3.20 |
Sbk1 |
SH3-binding kinase 1 |
3144 |
0.16 |
chr3_108592530_108592701 | 3.19 |
Wdr47 |
WD repeat domain 47 |
1226 |
0.27 |
chr11_54303826_54304909 | 3.18 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
165 |
0.94 |
chr6_55451730_55453138 | 3.18 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
257 |
0.93 |
chr16_75446825_75447522 | 3.17 |
Gm49678 |
predicted gene, 49678 |
120 |
0.98 |
chr14_34821027_34821671 | 3.17 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
1241 |
0.48 |
chr4_140245362_140247262 | 3.17 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr5_38158478_38159481 | 3.16 |
Nsg1 |
neuron specific gene family member 1 |
52 |
0.97 |
chr11_98325707_98326374 | 3.15 |
Neurod2 |
neurogenic differentiation 2 |
3608 |
0.12 |
chr2_152083384_152083946 | 3.15 |
Scrt2 |
scratch family zinc finger 2 |
2136 |
0.23 |
chr7_90886512_90887836 | 3.15 |
Gm45159 |
predicted gene 45159 |
102 |
0.88 |
chr11_120047221_120047929 | 3.12 |
Aatk |
apoptosis-associated tyrosine kinase |
408 |
0.71 |
chr11_120238467_120239478 | 3.12 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
2273 |
0.16 |
chr11_59288758_59290192 | 3.11 |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
1277 |
0.33 |
chr10_109010138_109010322 | 3.11 |
Syt1 |
synaptotagmin I |
732 |
0.77 |
chr5_38151138_38153189 | 3.11 |
Nsg1 |
neuron specific gene family member 1 |
6868 |
0.16 |
chr3_88210777_88211200 | 3.11 |
Gm3764 |
predicted gene 3764 |
1516 |
0.18 |
chr5_36868663_36870303 | 3.10 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr11_77486623_77487566 | 3.08 |
Ankrd13b |
ankyrin repeat domain 13b |
2572 |
0.17 |
chr9_41376046_41377501 | 3.08 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
212 |
0.93 |
chr1_124045018_124046369 | 3.08 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr5_113490881_113491656 | 3.07 |
Wscd2 |
WSC domain containing 2 |
516 |
0.83 |
chr1_120598097_120600876 | 3.07 |
En1 |
engrailed 1 |
2932 |
0.29 |
chr2_85197983_85199004 | 3.06 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr14_4855192_4856263 | 3.04 |
Gm3264 |
predicted gene 3264 |
151 |
0.94 |
chr11_119545665_119546015 | 3.04 |
Nptx1 |
neuronal pentraxin 1 |
1913 |
0.26 |
chr6_114041186_114042349 | 3.02 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
248 |
0.91 |
chr11_118907979_118908224 | 3.02 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
96 |
0.97 |
chr15_66285652_66286618 | 3.00 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
84 |
0.93 |
chr2_116056837_116059755 | 3.00 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr4_136834052_136834430 | 3.00 |
Ephb2 |
Eph receptor B2 |
1602 |
0.38 |
chr11_98327227_98329144 | 2.99 |
Neurod2 |
neurogenic differentiation 2 |
1463 |
0.23 |
chr3_95162734_95162933 | 2.99 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
1473 |
0.18 |
chr19_41740714_41741191 | 2.98 |
Slit1 |
slit guidance ligand 1 |
2534 |
0.3 |
chr3_89320679_89321987 | 2.98 |
Efna3 |
ephrin A3 |
298 |
0.73 |
chr6_134886811_134888239 | 2.98 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr4_122998794_122999794 | 2.98 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chr4_153478712_153478863 | 2.97 |
Ajap1 |
adherens junction associated protein 1 |
3392 |
0.38 |
chr5_37015516_37016196 | 2.96 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
12479 |
0.15 |
chr11_69835948_69836218 | 2.96 |
Nlgn2 |
neuroligin 2 |
1234 |
0.17 |
chr6_104492794_104494036 | 2.96 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr11_108926426_108927821 | 2.95 |
Axin2 |
axin 2 |
3942 |
0.24 |
chr17_8802429_8803035 | 2.94 |
Pde10a |
phosphodiesterase 10A |
296 |
0.93 |
chr8_84934799_84937325 | 2.94 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1282 |
0.19 |
chr2_74734325_74737080 | 2.94 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr11_70023477_70024664 | 2.93 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
150 |
0.87 |
chr7_99383478_99385192 | 2.92 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr14_4498814_4499998 | 2.92 |
Gm3173 |
predicted gene 3173 |
15352 |
0.11 |
chr11_55607331_55608633 | 2.92 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr14_4182195_4183376 | 2.92 |
Gm2974 |
predicted gene 2974 |
209 |
0.91 |
chr4_127988222_127989180 | 2.91 |
Csmd2 |
CUB and Sushi multiple domains 2 |
657 |
0.77 |
chr12_110187430_110189676 | 2.91 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr9_91378153_91379783 | 2.90 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chr7_123498761_123499242 | 2.90 |
Zkscan2 |
zinc finger with KRAB and SCAN domains 2 |
1448 |
0.47 |
chrX_134405492_134405850 | 2.89 |
Drp2 |
dystrophin related protein 2 |
869 |
0.59 |
chr11_97450155_97451075 | 2.87 |
Arhgap23 |
Rho GTPase activating protein 23 |
455 |
0.79 |
chr1_172025134_172025920 | 2.86 |
Vangl2 |
VANGL planar cell polarity 2 |
1184 |
0.38 |
chr15_83780142_83780827 | 2.86 |
Mpped1 |
metallophosphoesterase domain containing 1 |
461 |
0.86 |
chr1_189341351_189342108 | 2.86 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
1626 |
0.32 |
chr10_41070697_41071486 | 2.85 |
Gpr6 |
G protein-coupled receptor 6 |
1194 |
0.41 |
chr7_19175632_19177533 | 2.85 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr8_89036575_89038609 | 2.85 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr12_108556541_108556856 | 2.84 |
Gm16596 |
predicted gene, 16596 |
1080 |
0.43 |
chr5_114090407_114091746 | 2.83 |
Svop |
SV2 related protein |
291 |
0.84 |
chr2_24473566_24475385 | 2.83 |
Pax8 |
paired box 8 |
622 |
0.64 |
chrX_100767123_100768659 | 2.82 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
104 |
0.96 |
chr11_103649107_103650458 | 2.80 |
Rprml |
reprimo-like |
212 |
0.91 |
chr2_152080491_152081480 | 2.80 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr2_155514247_155515194 | 2.80 |
Ggt7 |
gamma-glutamyltransferase 7 |
128 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.9 | 8.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.8 | 8.5 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.3 | 30.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.3 | 6.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.0 | 7.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.9 | 5.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.9 | 7.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.8 | 1.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.8 | 5.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.8 | 5.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.7 | 8.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.6 | 3.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.6 | 4.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.6 | 3.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.5 | 6.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 4.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.5 | 7.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.4 | 7.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.4 | 4.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.4 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.4 | 1.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.4 | 5.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.4 | 4.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.4 | 4.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.3 | 10.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.3 | 5.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.2 | 3.7 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.2 | 17.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.2 | 2.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.2 | 3.5 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 4.6 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 3.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.1 | 5.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.1 | 6.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.1 | 3.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.1 | 13.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 5.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.1 | 3.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.1 | 1.1 | GO:0021586 | pons maturation(GO:0021586) |
1.1 | 4.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.0 | 9.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.0 | 4.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 3.0 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.0 | 4.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 2.0 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
1.0 | 7.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 2.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.9 | 2.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.9 | 0.9 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.9 | 7.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 1.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 3.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.9 | 11.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 2.7 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.9 | 10.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 2.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.8 | 3.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.8 | 4.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 3.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 2.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 2.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 7.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 2.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 1.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.8 | 0.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.8 | 1.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.8 | 26.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.8 | 2.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 2.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 6.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 2.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.7 | 4.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 2.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 2.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.7 | 13.9 | GO:0001964 | startle response(GO:0001964) |
0.7 | 12.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 3.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.7 | 5.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 1.4 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.7 | 2.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 0.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.7 | 2.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.7 | 2.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 5.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 35.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 2.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 1.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 1.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.6 | 6.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.6 | 1.9 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 1.9 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.6 | 0.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 0.6 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.6 | 3.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.6 | 0.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 1.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 2.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 1.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 1.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.6 | 8.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 2.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 1.7 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.6 | 1.7 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.6 | 1.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 5.6 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 0.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.6 | 9.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 5.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 1.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 2.7 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 1.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 4.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.5 | 1.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.5 | 7.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.5 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 2.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.5 | 3.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 1.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 2.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 3.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 1.5 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 1.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 1.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 0.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 6.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 3.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 1.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 1.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 7.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 3.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 1.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.5 | 1.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 2.7 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 0.9 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.4 | 1.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 2.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.4 | 7.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 12.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 1.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 3.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.7 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 0.9 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.4 | 1.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 0.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.4 | 5.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.4 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 3.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 1.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 0.8 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.4 | 4.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 0.4 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.4 | 1.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.4 | 2.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 3.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 2.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 3.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 1.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 0.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.8 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.4 | 2.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 4.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 0.4 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.4 | 0.7 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.4 | 1.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 1.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.4 | 2.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 3.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 3.5 | GO:0060384 | innervation(GO:0060384) |
0.3 | 0.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 1.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.3 | 0.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 1.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.3 | 1.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 3.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 1.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.3 | 3.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 2.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.3 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.3 | 0.6 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 10.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 1.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 1.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 6.0 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 2.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 4.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 2.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 1.1 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.8 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.3 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 2.7 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.3 | 4.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 1.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.5 | GO:0001975 | response to amphetamine(GO:0001975) |
0.3 | 1.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.5 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.3 | 3.6 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.3 | 0.8 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.2 | 0.5 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.2 | 0.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 6.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 2.7 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.7 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 2.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.7 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 1.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 16.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 4.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 1.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.5 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.2 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.4 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 2.5 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.2 | GO:0035283 | rhombomere development(GO:0021546) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 3.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 1.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 4.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 1.4 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 6.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 2.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.0 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 0.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.4 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 1.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 1.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 7.7 | GO:0099643 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
0.2 | 0.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 4.9 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 2.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 0.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 2.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.3 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 0.2 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.2 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.8 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.2 | 1.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 4.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.3 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 3.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 6.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 1.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.7 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.8 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.8 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.8 | GO:0021587 | cerebellum morphogenesis(GO:0021587) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 1.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.1 | 1.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 5.9 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.4 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.5 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.1 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 8.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 9.5 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.7 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 1.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.3 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.9 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 1.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.9 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.1 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.7 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.4 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.1 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.2 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.5 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.6 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 4.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.8 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 1.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.3 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 1.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.0 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 1.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.0 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 3.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:1900094 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.0 | 0.1 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.5 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.0 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.0 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 1.8 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 10.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.4 | 5.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.3 | 5.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.2 | 3.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.1 | 19.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 32.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 2.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 2.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 4.5 | GO:0008091 | spectrin(GO:0008091) |
0.9 | 8.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 19.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 6.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 2.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 4.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 8.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 25.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 13.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 2.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 5.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 7.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 1.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 5.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 2.7 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 2.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 18.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 1.4 | GO:0044393 | microspike(GO:0044393) |
0.5 | 4.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 4.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 4.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 0.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 12.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 41.3 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 2.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 7.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 0.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 16.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 35.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 6.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 3.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 4.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 11.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 27.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 2.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 8.7 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 2.0 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 44.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.4 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 4.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 2.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 12.7 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 19.2 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.8 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 7.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 12.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.5 | 7.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.1 | 6.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.0 | 6.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.8 | 12.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 8.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.5 | 5.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.4 | 4.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 5.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 9.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 6.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 6.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.2 | 3.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 10.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 4.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.0 | 3.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.0 | 7.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 2.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 2.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.9 | 5.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 4.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 4.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 2.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 9.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 2.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 13.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 9.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.7 | 2.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 3.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 7.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 4.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.7 | 9.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 1.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 3.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 5.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 2.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.6 | 3.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 2.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 2.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 2.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 4.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 2.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 5.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 5.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 10.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 2.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 5.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.8 | GO:0033265 | choline binding(GO:0033265) |
0.5 | 4.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 1.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 5.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 0.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 3.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 0.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 7.9 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 2.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 1.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 8.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 2.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 4.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 5.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 2.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 4.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 3.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 3.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 8.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 3.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 6.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 7.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 3.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 2.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 3.6 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 0.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 4.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 6.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 8.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 4.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 0.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 9.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 5.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 5.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.3 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 6.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 6.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 2.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 5.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 5.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 2.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 2.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 4.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 2.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 2.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 3.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 3.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 1.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 1.3 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 6.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.8 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0034922 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 3.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 6.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 16.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 2.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 2.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 1.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 4.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 3.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.9 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.5 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 2.3 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 7.1 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.0 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.2 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 12.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 7.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 10.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 11.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 11.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 3.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 6.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 10.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 5.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 4.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 5.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 2.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.0 | 12.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 16.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 10.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.8 | 12.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 10.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 6.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 9.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 5.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 2.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 12.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 5.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 5.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 3.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 18.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 5.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 4.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 8.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 5.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 8.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 12.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 6.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 3.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 4.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 0.8 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.2 | 3.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 20.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 7.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.2 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.2 | 4.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 1.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 11.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 2.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 2.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |